BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2024 07:00 ET
|
BioCryst Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, N.C., July 02, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted...
G1 Therapeutics Added to the Russell 2000® and 3000® Indexes
July 01, 2024 08:00 ET
|
G1 Therapeutics
G1 Therapeutics Added to the Russell 2000® and 3000® Indexes
Humacyte Acellular Tissue Engineered Vessel (ATEV™) Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for Patients with Advanced Peripheral Artery Disease (PAD)
July 01, 2024 08:00 ET
|
Humacyte, Inc
– Third RMAT designation by FDA for ATEV – – RMAT will expedite development of ATEV in PAD – DURHAM, N.C., July 01, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage...
Fennec Pharmaceuticals Announces Management Change
July 01, 2024 06:00 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, N.C., July 01, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that Adrian...
Fortrea Lança AI Innovation Studio para Galvanizar Tecnologia e Soluções Humanas para Aprimoramento da Entrega de Ensaios Clínicos
June 28, 2024 10:08 ET
|
Fortrea Holdings Inc
DURHAM, N.C., June 28, 2024 (GLOBE NEWSWIRE) -- A Fortrea (Nasdaq: FTRE), uma organização líder global de pesquisa por contrato (CRO), anunciou hoje o lançamento do seu AI Innovation Studio,...
Fortrea Melancarkan Studio Inovasi AI untuk Merangsang Penyelesaian Teknologi dan Manusia Penghantaran Percubaan Klinikal
June 28, 2024 10:08 ET
|
Fortrea Holdings Inc
DURHAM, N.C., June 28, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), organisasi penyelidikan kontrak (CRO) global terkemuka, hari ini mengumumkan pelancaran Studio Inovasi Kecerdasan Buatan (AI),...
Fortrea Meluncurkan Studio Inovasi AI untuk Memacu Solusi Teknologi dan Manusia guna Meningkatkan Penyelenggaraan Uji Klinis
June 28, 2024 10:08 ET
|
Fortrea Holdings Inc
DURHAM, N.C., June 28, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), sebuah organisasi penelitian kontrak (CRO) global terkemuka, hari ini mengumumkan peluncuran Studio Inovasi AI, dengan...
Fortrea startet KI-Innovationsstudio, um Technologie und menschliche Lösungen zur Verbesserung der Durchführung klinischer Studien zu bündeln
June 28, 2024 10:08 ET
|
Fortrea Holdings Inc
DURHAM, N.C., June 28, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), ein führendes globales Auftragsforschungsinstitut (CRO), gab heute die Einführung seines Innovationsstudios für künstliche...
Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials
June 27, 2024 09:41 ET
|
Science 37, Inc.
Nearly 20 studies have successfully leveraged Science 37's medical and operational expertise to boost patient recruitment and enrollment activities.
Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery
June 27, 2024 07:00 ET
|
Fortrea Holdings Inc
DURHAM, N.C., June 27, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the launch of its artificial intelligence (AI)...